Skip to content
Saturday, November 7, 2026
iGamingSpot UK

Zimbabwe Rejects ‘Lopsided’ US Healthcare Assistance Agreement Over Information Fears

Health aid image
The offered American financial assistance was intended for initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has turned down a substantial American health deal valued at $367m (£272m) over five years due to Washington's request for sensitive biological samples.

This move was revealed after a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".

A government spokesperson later clarified that the United States was demanding access to health data for research and profit while was unwilling to guarantee the resulting advantages from any future treatments.

"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for continued talks to reach a agreement agreeable to all parties so the nation's critical HIV programme can proceed.

Wider Context

This development comes after a comparable situation in neighbouring Kenya, where a high court suspended a similar deal with the US following legal challenges were raised about the safety of Kenyans' health data.

Since returning to office recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had managed aid for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.

According to statements, 16 African countries have so far agreed to these new health pacts, constituting more than $18.3bn in committed funds.

Specifics of the Rejected Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," the Ambassador said.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.

"In essence, our country would supply the raw materials for scientific discovery with no assurance that the end products would be available to our citizens if a new disease outbreak emerge."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting systems previously established through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to manage potential global health emergencies.

"This framework is designed to ensure that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."

Zimbabwe's reservations regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage continued dialogue with our US partners on how future co-operation could be structured in a manner that respects the sovereignty and dignity of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the official position, but recommended that talks must proceed since much of the country's HIV programmes depended on external financing.

"In cases where technical issues arise, such as those involving information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," the group added.

This impasse underscores the complex challenges between accepting much-needed international aid and safeguarding national sovereignty in an ever more interconnected world.

JW
The writer

Jeffrey Wheeler

A seasoned gaming journalist with over a decade of experience covering the UK iGaming industry and regulatory trends.

iGamingSpot UK

Type to search articles.